Telcare, a US-based provider of monitors that let people know their blood-sugar levels, has raised $25.5m in its series B round from a consortium including chip maker Qualcomm’s $100m Life corporate venturing fund.

Venture capital firm Sequoia Capital led the B round, which followed a $4.5m A round from a consortium also including Qualcomm at the end of last year. Telcare was founded in 2008.

Jack Young, director of Qualcomm Ventures and head if the Kife Fund, said: “Telcare’s solution leverages the broad coverage of mobile networks and the convenience of cellular technology to empower individuals to better manage their conditions through professional supervision and/or family members’ support.”

The two investors had also been part of a syndicate backing remote patient monitoring company AirStrip Technologies in February. Qualcomm Life Fund was set up in December from the existing allocation for Qualcomm Ventures, with an aim to help roll out Qualcomm’s…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?